Given IGF-I’s neuroprotective properties, it has been proposed that reduced IGF-I levels and decreased sensitivity of IGF-IR in the brain contribute to increased vulnerability to AD [90,91]. The gene discussed is IGF1; the disease is Alzheimer disease.